NCT00607061

Brief Summary

The aim of the study is to determine mechanisms leading to glutathione deficiency in low birth weight newborn babies. Compared to full term neonates, depletion in this population may be due to a decreased synthesis rate or to an enhanced utilization or a combination of both mechanisms.The protocol is constituted of two steps. The objective of the first step is to quantify the blood concentration of glutathione in the artery and the vein of umbilical cord in full term newborn babies. Objectives of the second step are to determine if the glutathione synthesis rate, measured in vitro, is lower in erythrocytes collected from umbilical cord blood of low weight newborn babies compared to full term newborn babies. In this case, the next objective will be to determine if the adjunction of an excess of cysteine in vitro can restore the glutathione synthesis rate in these cells.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
35

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2007

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2007

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

January 22, 2008

Completed
14 days until next milestone

First Posted

Study publicly available on registry

February 5, 2008

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2010

Completed
Last Updated

September 30, 2013

Status Verified

September 1, 2013

Enrollment Period

2.8 years

First QC Date

January 22, 2008

Last Update Submit

September 27, 2013

Conditions

Keywords

GlutathioneCysteineSynthesis rateNewbornsLow birth weight newborn babies

Outcome Measures

Primary Outcomes (1)

  • The glutathione concentration in umbilical cord in full term newborn babies, the glutathione concentration in umbilical cord of low birth weight newborn babies and the effect of the adjunction of an excess of cysteine on the glutathione synthesis rate.

Study Arms (3)

1

OTHER

Full term newborn babies with gestational age \> 37 weeks of amenorrhea and weight of birth \> tenth percentile.

Procedure: Blood sample collection

2

OTHER

Low birth weight newborn babies (gestational age \< 32 weeks of amenorrhea and/or weight of birth \< 1500 g and/or weight of birth \< third percentile for their gestational age.

Procedure: Blood sample collection

3

OTHER

Full term newborn babies (gestational age \> 37 weeks of amenorrhea and weight of birth \> tenth percentile).

Procedure: Blood sample collection

Interventions

Blood of the umbilical cord will be collected after delivery. A mother blood sample will be also collected in the few hours preceding delivery to determine glutathione and cysteine concentrations.

123

Eligibility Criteria

AgeUp to 9 Months
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Full term newborn babies
  • Gestational age \> 37 weeks of amenorrhea and weight of birth \> tenth percentile
  • Eutocic delivery
  • Low birth weight newborn babies (gestational age \< 32 weeks of amenorrhea and/or weight of birth \< 1500 g and/or weight of birth \< third percentile for their gestational age)
  • Full term newborn babies (gestational age \> 37 weeks of amenorrhea and weight of birth \> tenth percentile)

You may not qualify if:

  • Mother diastolic blood pressure \> 90 mmHg during pregnancy,
  • pH \< 7.2 at umbilical cord and/or difference in pH \< 0,02 between arterial pH and venous pH
  • Dystocic delivery
  • Bacterial or viral maternofoetal infection
  • Foetal malformation
  • Foetal disease
  • Taking N-acetyl-cystein or vitamines and antioxidant minerals by the mother for the last 24 hours

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU de Nantes

Nantes, Nantes, 44000, France

Location

Related Publications (1)

  • De Luca A, Kuster A, Tea I, Darmaun D, Roze JC, Robins R, Hankard R. Plasma amino acid pools in the umbilical cord artery show lower 15N natural isotope abundance relative to the maternal venous pools. Isotopes Environ Health Stud. 2021 Mar;57(1):3-10. doi: 10.1080/10256016.2020.1817914. Epub 2020 Sep 24.

Study Officials

  • Alice KUSTER, Doctor

    Nantes University Hospital

    PRINCIPAL INVESTIGATOR
  • Norbert WINER, Doctor

    Nantes University Hospital

    STUDY CHAIR
  • Jean-Christophe ROZE, Professor

    Nantes University Hospital

    STUDY CHAIR
  • Dominique DARMAUN, Professor

    Nantes University Hospital

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER

Study Record Dates

First Submitted

January 22, 2008

First Posted

February 5, 2008

Study Start

October 1, 2007

Primary Completion

July 1, 2010

Study Completion

July 1, 2010

Last Updated

September 30, 2013

Record last verified: 2013-09

Locations